Three New Studies Confirm Power of Booster Shots Against Omicron

By Robin Foster, HealthDay Reporter> Friday, January 21, 2022 — Three new government studies show that booster shots prevent the Omicron variant from landing millions of Americans in hospitals, emergency rooms and urgent care clinics across the country. In a study published Friday in the US Centers for Disease Control and Prevention, Mortality and Mortality … Read more

MS House Passes MedMJ Bill, MO Drug Decriminalization Bill Filed, More… (1/20/22)

A marijuana service company has filed a federal lawsuit over massive cash confiscation by cops in California and Kansas, the Colombian Constitutional Court is placing kibosh on spraying coca crops with herbicide, and more. Colombian coca farmers won’t have to worry about dumping toxic herbicides on their fields. (DEA) medical marijuana Mississippi House amends medical … Read more

COVID Rapid Test Makers Struggling to Meet Demand

FRIDAY, Jan 21, 2022 — A lack of supplies and workers is wreaking havoc on efforts by home COVID test makers to get Americans enough testing, even as the federal government pledges 500 million for free, in home kits. Like many other companies, test kit manufacturers “have too many of their employees with COVID. So … Read more

Many Marijuana Vendors Aim Advertising at Kids: Study

By Dennis Thompson, HealthDay reporter> Friday, January 21, 2022 — Some gadget stores are using old playbook scams from alcohol and tobacco companies to target underage users on social media, according to a new study. Despite state laws restricting such marketing, researchers have found that marijuana retailers on social media promote their goods through posts … Read more

New opportunity to induce remission of peanut allergy in young children through oral immunotherapy

A clinical trial funded by the National Institutes of Health found that giving a peanut immunotherapy to children with severe peanut allergies between the ages of 1 and 3 years safely removes allergies to mostly peanuts and induces remission of peanut allergies in five. Immunotherapy consisted of a daily oral dose of peanut flour for … Read more

Study shows efficacy, safety of oral immunotherapy in one- to three-year-olds with peanut allergy

The majority of young children treated with peanut immunotherapy achieved allergy after two and a half years of treatment, and one in five remained in remission 26 weeks after treatment ended, according to a randomized controlled trial published in scalpel. Achievement of remission was more common the younger the child was at the start of … Read more

A validated risk-stratification system to manage COVID-19 outpatients

The massive increase in the number of coronavirus disease (COVID-19) cases has made it difficult for healthcare providers around the world to manage the huge number of patients arriving at hospital outpatient departments. Although there are multiple scoring systems developed to analyze mortality risk among critically ill and inpatients, such a procedure for monitoring disease … Read more

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study is currently available at bioRxiv * Prepress server shows that a new protease inhibitor known as nirmatrelvir has potent activity against the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in Reducing disease burden from coronavirus … Read more